Case Note & Summary
The appeal arose from a judgment of the Bombay High Court which dismissed a criminal writ petition filed by the appellants, directors of Cachet Pharmaceuticals Private Ltd. (CPPL), challenging the issuance of process against them under the Drugs and Cosmetics Act, 1940. The case stemmed from allegations that 'Hemfer Syrup' manufactured by CPPL was not of standard quality, leading to a complaint filed by the Drug Inspector. The appellants contended that the complaint did not specify their roles in the alleged offence, as required under Section 34 of the Act, which holds individuals responsible only if they were in charge of and responsible for the conduct of the business at the time of the offence. The court analyzed the complaint and found it lacking in specific averments against the appellants, noting that they were neither managing nor whole-time directors. The court also highlighted the requirement for the magistrate to apply judicial mind and provide reasons when issuing process, which was absent in this case. Consequently, the Supreme Court quashed the orders of the lower courts and dismissed the complaint against the appellants, allowing the appeal and stating that the complaint could proceed against the remaining accused as per law.
Headnote
A) Criminal Law - Vicarious Liability - Requirement of Specific Averments - Drugs and Cosmetics Act, 1940, Section 34 - The court held that mere designation as directors does not suffice for liability; specific averments regarding their role in the conduct of business are necessary. The complaint lacked such specifics, leading to quashing of proceedings against the appellants. (Paras 22-24) B) Criminal Procedure - Issuance of Process - Requirement of Judicial Application of Mind - Code of Criminal Procedure, 1973, Section 204 - The court emphasized that a magistrate must provide reasons for issuing process, and failure to do so renders the order invalid. The absence of a formal order of issuance was noted, leading to the quashing of the process. (Paras 26-30)
Issue of Consideration
Whether the appellants, as directors of the company, could be held liable under the Drugs and Cosmetics Act, 1940 for the alleged offence without specific averments regarding their role.
Final Decision
The Supreme Court allowed the appeal, quashed the orders of the lower courts, and dismissed the complaint against the appellants, stating that the complaint lacked necessary specifics to hold them liable under the Drugs and Cosmetics Act.
Law Points
- Vicarious liability
- Criminal procedure
- Issuance of process
- Compliance with statutory requirements
- Standards of drug quality
